Jaipur
08042782001
+918824471531

Obeticholic Acid 5 mg Tablets : Advanced Liver Sup...

Obeticholic Acid 5 mg Tablets : Advanced Liver Support with Obeticholic Acid 5 mg

Liver health plays a critical role in overall well-being, affecting everything from digestion and metabolism to hormonal balance and detoxification. For individuals suffering from chronic liver conditions like Primary Biliary Cholangitis (PBC), targeted therapies are essential to slow disease progression and improve quality of life. OB-COLLAR 5, powered by Obeticholic Acid 5 mg, is a breakthrough treatment designed to support and protect liver function.

Introduction to OB-COLLAR 5

OB-COLLAR 5 contains Obeticholic Acid, a semi-synthetic bile acid analogue that works as a farnesoid X receptor (FXR) agonist. FXR plays a key role in regulating bile acid production and transport, making it a crucial target in treating cholestatic liver diseases.

This advanced medication is FDA-approved for the treatment of Primary Biliary Cholangitis (PBC), especially in patients who show inadequate response to or intolerance of ursodeoxycholic acid (UDCA). OB-COLLAR 5 helps to reduce bile acid buildup, thereby relieving inflammation, protecting liver cells, and slowing disease progression.

Key Benefits of OB-COLLAR 5

OB-COLLAR 5 offers several proven benefits for patients managing chronic liver disease:

  • Reduces bile acid accumulation in the liver

  • Slows fibrosis and progression of PBC

  • Improves liver enzyme levels, including ALP and bilirubin

  • Supports better liver function and detoxification

  • Provides an option for patients unresponsive to first-line therapy

  • Well-tolerated with a favorable safety profile

Key Features and Ingredients

Key Features:

  • Targeted therapy for Primary Biliary Cholangitis

  • Once-daily oral dosage for convenient use

  • Can be used as monotherapy or in combination with UDCA

  • Scientifically backed by clinical research and global usage

  • Designed for long-term liver support

Active Ingredient:

  • Obeticholic Acid 5 mg – A potent FXR agonist that regulates bile acid synthesis, reduces liver inflammation, and prevents scarring of liver tissue.

How to Use OB-COLLAR 5

Recommended Dosage:

  • Initial dosage: 5 mg once daily

  • If well tolerated, the dose may be increased to 10 mg once daily after 3 months, based on therapeutic response and liver enzyme levels.

Administration:

  • Can be taken with or without food

  • Regular monitoring of liver function tests (LFTs) is advised

  • Always follow the dosage regimen as prescribed by your physician

Precautions:

  • Not recommended for use in patients with decompensated cirrhosis without close monitoring

  • Use with caution in patients with severe hepatic impairment

  • May cause pruritus in some individuals; dose adjustment or supportive treatment may be required

Additional Benefits of OB-COLLAR 5

OB-COLLAR 5 is not just another liver supplement — it is a clinically validated therapy aimed at improving liver structure and function. For patients with PBC, it provides:

  • A lifeline when standard therapies fail

  • Improved biochemical markers of liver injury

  • Reduced need for liver transplant in responsive patients

  • Long-term liver protection with continued use

It also holds potential benefits in other cholestatic liver conditions under research, making it a promising tool for advanced hepatology care.

Conclusion

OB-COLLAR 5, with Obeticholic Acid 5 mg, stands at the forefront of modern hepatology treatment. As a targeted FXR agonist, it provides meaningful clinical outcomes in managing Primary Biliary Cholangitis, especially for those who do not respond adequately to UDCA alone. With its proven ability to reduce bile acid toxicity and liver inflammation, OB-COLLAR 5 offers a pathway to better liver health and improved quality of life.

Choose OB-COLLAR 5 – advanced care for progressive liver conditions.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

 2025-05-10T09:54:03

Keywords